De-risking nasal & pulmonary formulation development

To deliver therapeutics effectively to the nasal and pulmonary regions, developers must address the physiological barriers in these tissues. This webinar covers how formulation techniques and early in vitro toxicology work together to accelerate development and reduce risk.

Date: 13/04/2026
Author ImmuONE
DateCategory Watch Time 37 minutes To deliver therapeutics effectively to the nasal and pulmonary regions, developers must address the physiological barriers in these tissues. This webinar covers how formulation techniques and early in vitro toxicology work together to accelerate development and reduce risk. It explains the value of confirming structural and functional integrity early, highlights the benefits of spray‑drying for stability, particle control, and excipient incorporation, and outlines how toxicology and permeability testing provide evidence of safety and therapeutic potential.

Watch the full webinar

Watch the webinar to explore insights that support informed development and formulation assessment.

Speak to the team

If you’d like to discuss ImmuONE’s capabilities in nasal and pulmonary in vitro assessment, please contact the team.

Add a Comment

Related Posts